PA
GMAB icon

Parallel Advisors’s Genmab GMAB Stock Holding History

Parallel Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
6,091
+1,220
+25% +$32.4K ﹤0.01% 1389
2026
Q1 		$131K Buy
4,871
+669
+16% +$20K ﹤0.01% 1429
2025
Q4 		$129K Buy
4,202
+63
+2% +$1.96K ﹤0.01% 1327
2025
Q3 		$127K Buy
4,139
+419
+11% +$10.2K ﹤0.01% 1287
2025
Q2 		$76.8K Buy
3,720
+2,941
+378% +$60.4K ﹤0.01% 1488
2025
Q1 		$15.2K Sell
779
-2,529
-76% -$53K ﹤0.01% 2264
2024
Q4 		$69K Buy
3,308
+2,688
+434% +$59.1K ﹤0.01% 1458
2024
Q3 		$15.1K Buy
620
+220
+55% +$5.88K ﹤0.01% 2226
2024
Q2 		$10.1K Sell
400
-1,293
-76% -$36.7K ﹤0.01% 2311
2024
Q1 		$50.6K Buy
1,693
+671
+66% +$19.7K ﹤0.01% 1492
2023
Q4 		$32.5K Sell
1,022
-206
-17% -$6.47K ﹤0.01% 1657
2023
Q3 		$43.3K Buy
1,228
+70
+6% +$2.67K ﹤0.01% 1460
2023
Q2 		$44K Buy
1,158
+410
+55% +$16.3K ﹤0.01% 1466
2023
Q1 		$28.2K Buy
748
+80
+12% +$3.08K ﹤0.01% 1657
2022
Q4 		$28.3K Sell
668
-430
-39% -$17.7K ﹤0.01% 1557
2022
Q3 		$35K Buy
1,098
+470
+75% +$16.5K ﹤0.01% 1416
2022
Q2 		$20K Sell
628
-410
-39% -$13.3K ﹤0.01% 1665
2022
Q1 		$38K Sell
1,038
-324
-24% -$11.1K ﹤0.01% 1410
2021
Q4 		$54K Sell
1,362
-550
-29% -$22.9K ﹤0.01% 1277
2021
Q3 		$84K Buy
1,912
+560
+41% +$25.1K ﹤0.01% 1053
2021
Q2 		$55K Buy
1,352
+360
+36% +$13.9K ﹤0.01% 1204
2021
Q1 		$33K Sell
992
-60
-6% -$2.26K ﹤0.01% 1363
2020
Q4 		$43K Buy
1,052
+60
+6% +$2.24K ﹤0.01% 1162
2020
Q3 		$36K Buy
992
+260
+36% +$9.4K ﹤0.01% 1196
2020
Q2 		$24K Buy
732
+510
+230% +$13.9K ﹤0.01% 1336
2020
Q1 		$4K Sell
222
-10
-4% -$223 ﹤0.01% 1958
2019
Q4 		$5K Buy
+232
New +$5.06K ﹤0.01% 1956

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parallel Advisors's GMAB Position: Q2 2026 in Review

Parallel Advisors increased its Genmab (GMAB) stake by 25% in Q2 2026, buying an estimated $32.4K and bringing the position to 6,091 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

Parallel Advisors first reported a position in GMAB in Q4 2019 and has held it in 27 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Parallel Advisors held 6,091 shares of Genmab worth $167K as of Q2 2026.
  • Parallel Advisors bought 1,220 Genmab shares in Q2 2026, an estimated $32.4K.
  • Genmab made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1389 holding.
  • Parallel Advisors first reported a position in Genmab in Q4 2019 and has held it in 27 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.